| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |